Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database.

Allignol, Arthur; Boutmy, Emmanuelle; Sabidó Espin, Meritxell; Marhardt, Kurt; Vermersch, Patrick

Allignol, Arthur; Boutmy, Emmanuelle; Sabidó Espin, Meritxell; Marhardt, Kurt; Vermersch, Patrick.

Afiliação

Allignol A; Merck Healthcare KGaA, Darmstadt, Germany.
Boutmy E; Merck Healthcare KGaA, Darmstadt, Germany.
Sabidó Espin M; Merck Healthcare KGaA, Darmstadt, Germany.
Marhardt K; Merck Gesellschaft mbH (an affiliate of Merck KGaA), Vienna, Austria.
Vermersch P; Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.

Front Neurol ; 12: 676585, 2021.

Article em En | MEDLINE | ID: mdl-34381411

Palavras-chave

adherence; age; healthcare utilization; multiple sclerosis; relapse; subcutaneous interferon beta-1a

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google